Provided by Tiger Trade Technology Pte. Ltd.

Prestige

46.68
-0.9400-1.97%
Pre-market: 46.47-0.2100-0.45%06:58 EDT
Volume:767.13K
Turnover:36.06M
Market Cap:2.21B
PE:13.06
High:48.25
Open:47.22
Low:46.38
Close:47.62
52wk High:71.07
52wk Low:42.62
Shares:47.32M
Float Shares:46.69M
Volume Ratio:1.54
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.58
EPS(LYR):3.91
ROE:9.12%
ROA:4.58%
PB:1.15
PE(LYR):11.94

Loading ...

Prestige Consumer Healthcare: Lacorium Expected to Generate About $12 Mln in Ebitda Including Benefits From Synergies Once Business Fully Integrated

THOMSON REUTERS
·
May 14

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of Lacorium Health

THOMSON REUTERS
·
May 14

U.S. Earnings Preview: After Market Close May 13

Dow Jones
·
May 14

NITCO Receives Additional Marble Order Worth INR667 Million From Prestige Estates; Shares Jump 5%

MT Newswires Live
·
May 13

Prestige International Sees FY Net Y5.92B

Dow Jones
·
May 13

Prestige Consumer Healthcare SVP Operations Jeffrey Zerillo disposes 656 shares worth $35,683.61

Reuters
·
May 12

Buy Rating Reaffirmed on PBH with Earnings Growth Drivers, Balance Sheet Improvement and Unchanged $140 Price Target

TIPRANKS
·
May 12

MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing

GlobeNewswire
·
May 11

Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 37% One-Year Share Price Drop?

Simply Wall St.
·
May 10

Stifel Nicolaus Keeps Their Buy Rating on Premium Brands (PBH)

TIPRANKS
·
May 08

Top Prestige Consumer Executive Makes Notable Stock Move

TIPRANKS
·
May 08

Prestige Consumer price target lowered to $65 from $77 at Oppenheimer

TIPRANKS
·
May 07

Prestige Consumer Healthcare : Oppenheimer Cuts Target Price to $65 From $77

THOMSON REUTERS
·
May 07

Press Release: MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights

Dow Jones
·
May 07

MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award

GlobeNewswire
·
May 07

Press Release: Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Prestige Consumer Healthcare Senior VP Operations Jeffrey Zerillo disposes 1,589 shares for $86,993.76

Reuters
·
May 07

RBC Capital Reaffirms Their Buy Rating on Premium Brands (PBH)

TIPRANKS
·
May 06

Earning Preview: Prestige this quarter’s revenue is expected to increase by 1.86%, and institutional views are bullish

Earnings Agent
·
May 06

Premium Brands (PBH) Receives a Buy from CIBC

TIPRANKS
·
Apr 30